Thus, the company’s capital will go up from RON33.2 million to RON132.87 million through the issuance of 398,611,476 new shares with a nominal value of RON 0.25/share. The increase of the Share Capital will be carried out to support the current activity of the company.
The Share Capital Increase will be carried out through the incorporation of share premiums and reserves (with the exception of the legal reserves), and the newly issued shares will be allocated free of charge to the Company’s shareholders registered in the register of shareholders kept by Depozitarul Central – S.A. as of 04.09.2023, established as record date (“Record Date”). Each shareholder registered in the register of shareholders kept by Depozitarul Central – S.A. on the Record Date will receive 3 (three) newly issued shares, free of charge for each share held on the Record Date.
MedLife will publish 1H/2023 financial results on August 25. In the first three months of the year, the company posted RON529 million consolidated turnover, up 26.4% from last year. Net profit dropped from RON29.5 million to RON8.4 million.
The company’s shares have added 13.5% this year.
(English version by Catalina Apostoiu)